0000000000617613

AUTHOR

V. Tierbach

showing 1 related works from this author

Anti-hormonal maintenance treatment with or without the CDK4/6 inhibitor ribociclib after first line chemotherapy in hormone receptor positive/HER2 n…

2018

Oncologymedicine.medical_specialtybusiness.industryHER2 negativeRibociclibHematologymedicine.diseaseMetastatic breast cancerOncologyHormone receptorInternal medicinemedicineFirst line chemotherapybusinessHormoneAnnals of Oncology
researchProduct